Because of COVID-19, many of us have postponed elective procedures this year—and that includes mammograms. In this episode, LA-based oncologist Natasha Banerjee discusses the alarming drop in breast cancer screenings since March—and the ramifications. Plus an update on the latest treatments like immunotherapy which utilizes antibodies to boost immunity; who should be getting ultrasounds and or MRIs to screen for breast cancer; how you can tell if you have dense breasts and should be getting ultrasounds; and a rare cancer that has been linked to one type of implants.